مراجعةوصول مفتوح2026
Cureus · مجلد 18 (8) · e114308-e114308
The optimal noninvasive respiratory support for infants and children with severe viral bronchiolitis remains unclear. While continuous positive airway pressure (CPAP) has traditionally been considered the gold standard, high-flow nasal cannula (HFNC) therapy is a better-tolerated alternative. This systematic review and meta-analysis aimed to evaluate the comparative efficacy and safety of HFNC versus noninvasive ventilation (NIV) in pediatric patients with bronchiolitis-associated acute respiratory failure. We searched major electronic databases through June 2026. We included randomized controlled trials (RCTs) and observational cohorts comparing HFNC with NIV (CPAP/bilevel positive airway pressure (BiPAP)). The primary outcomes were treatment failure, as defined by the individual studies, and endotracheal intubation. Data were synthesized using random-effects models, and heterogeneity was explored via subgroup analysis and meta-regression. Eleven studies (seven RCTs and four observational studies) comprising 7,574 patients were included. There was no statistically significant difference in the overall risk of treatment failure between HFNC and NIV (RR 1.99, 95% CI 0.65-6.10); however, study design was a significant moderator (p = 0.0019). Observational studies reported significantly higher failure rates with HFNC (RR 7.78), whereas RCTs showed no significant difference (RR 1.11). There were no significant differences in endotracheal intubation rates (RR 0.75, 95% CI 0.51-1.09) or pediatric intensive care unit length of stay (MD -0.16 days, 95% CI -0.79 to 0.47) between the groups. HFNC demonstrated a trend toward fewer local adverse events, such as nasal/skin trauma (RR 0.30, 95% CI 0.06-1.52), than did NIV. The certainty of evidence according to GRADE was low for all outcomes. HFNC showed no significant differences from NIV in critical clinical endpoints, including intubation rates and intensive care duration. Differences in treatment failure rates appeared to be influenced by study design, highlighting potential confounding by indication in observational data. Given its improved tolerability and trend toward reduced mucosal trauma, HFNC may represent a viable first-line noninvasive intervention for pediatric bronchiolitis.
high-flow nasal cannulanon-invasive ventilationpediatric bronchiolitisacute respiratory failure
مراجعةوصول مفتوح2025
Journal of Health and Rehabilitation Research · 1-10
Background: Traumatic brain injury (TBI) is a leading cause of trauma-related mortality and disability, necessitating rapid and effective airway management to prevent secondary brain injury. Establishing a definitive airway before hospital admission is often performed in the prehospital setting; however, its impact on patient outcomes remains debated. Objective: This study aimed to assess the effectiveness of prehospital advanced airway management in TBI patients by comparing mortality and morbidity outcomes between prehospital and in-hospital intubation. Methods: A systematic review was conducted following PRISMA guidelines. Five electronic databases were searched, and data extraction was performed using Endnote. Inclusion criteria encompassed observational studies, cohort studies, and randomized controlled trials (RCTs) evaluating prehospital intubation. The Newcastle-Ottawa Scale (NOS) was used to assess the risk of bias, and statistical analysis was performed to evaluate mortality and morbidity trends. Results: Despite considerable heterogeneity, no statistically significant difference in mortality was observed between prehospital and in-hospital intubation (OR = 1.08, 95% CI: 0.89–1.27, p = 0.32). However, sensitivity analysis suggested a 12% reduction in morbidity with prehospital intubation (RR = 0.88, 95% CI: 0.79–0.96), particularly when performed by trained professionals following standardized protocols. Studies incorporating rapid sequence intubation (RSI) and capnography monitoring reported improved neurological outcomes, with a 15–20% increase in favorable Glasgow Outcome Scale (GOS) scores compared to non-RSI approaches. Variability in intervention techniques, prolonged on-scene times, and inconsistent ventilation management contributed to conflicting findings, underscoring the necessity of cautious interpretation due to data variability. Conclusion: While prehospital intubation remains a critical intervention in TBI management, its superiority over in-hospital intubation remains uncertain. Standardized protocols, RSI implementation, provider training, and further high-quality RCTs are essential to establish its clinical efficacy and optimize patient outcomes.
traumatic brain injuryprehospital intubationadvanced airway managementrapid sequence intubation
مراجعةوصول مفتوح2021
International Journal of Community Medicine and Public Health · مجلد 8 (6) · 3127-3127
Corona viruses are enveloped, positive-sense, single-stranded large RNA viruses that affect humans and many animals. About 5% of COVID-19 patients need ICU admission due to ARDS, with a case fatality rate varying from 30% to 60%. Some patients need help other than supplementary oxygen, such as non-invasive ventilation or intubation. Before deciding the appropriate respiratory support for acute respiratory failure patients, concerns regarding the dangers of various treatments should be considered. During the treatment of COVID-19 patients, all respiratory therapies face a risk of aerosol-generating procedures. When treating COVID-19 patients, the priority and consideration should be personal safety devices and environmental control/engineering.
COVID-19 pandemicacute respiratory failureacute respiratory distress syndromemechanical ventilation